Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Introduction<p>T cell receptor-engineered T cell therapy has emerged as a promising approach in cancer immunotherapy, leveraging the ability of T cells to recognize tumor antigens presented on major histocompatibility complex molecules, offering a targeted approach for treating cancers. This s...

全面介紹

Saved in:

書目詳細資料
主要作者:	Saleh Alrhmoun (19193851) (author)
其他作者:	Roman Perik-Zavodskii (19193839) (author), Marina Fisher (19828437) (author), Julia Lopatnikova (4164058) (author), Olga Perik-Zavodskaia (19193842) (author), Julia Shevchenko (19193845) (author), Kirill Nazarov (19193854) (author), Julia Philippova (19828440) (author), Vasily Kurilin (19828443) (author), Olga Kichakova (22680860) (author), Evgenii Zavjalov (12230774) (author), Elena Golikova (472121) (author), Petr Timashev (10031740) (author), Petr Glybochko (13011754) (author), Sergey Sennikov (4164055) (author)
出版:	2025
主題:	Genetic Immunology TCR-T cells TCR-T T cells adoptive cell therapy her2/neu ErbB2 ScRNA-seq
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

相似書籍